Key facts
- WS Audiology’s last known valuation is $2.6B (Jan 2015).
- It has raised $10.0B; the latest was Debt Refinancing in Jan 2026.
- Notable investors include T&W Medical, Lundbeckfonden, Ardian France, Athos (Family Office), EQT — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for WS Audiology
- ·The full record, as it builds
Funding rounds
No funding rounds for WS Audiology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About WS Audiology
Developer and manufacturer of leading-edge hearing aids designed for better hearing and understanding. The company's product spectrum covers the full range of hearing aids and accessories across all price categories and is sold via several brands, enabling patients suffering from hearing loss to live an improved life.
- Sector
- Healthcare
- HQ
- Lynge, Denmark
- Founded
- 1877
- Employees
- 12,000
- Website
- wsa.com/
- Ownership
- Privately Held (backing)
WS Audiology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in WS Audiology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on WS Audiology in its N-PORT filings yet. We sweep new filings monthly.